AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,412 | -91.2% | 11,718 | -72.2% | 0.00% | -100.0% |
| Q4 2021 | $95,254 | -31.4% | 42,148 | -12.6% | 0.00% | -50.0% |
| Q3 2021 | $138,856 | +31.1% | 48,214 | +72.5% | 0.00% | +100.0% |
| Q2 2021 | $105,949 | -28.3% | 27,955 | -36.0% | 0.00% | -50.0% |
| Q1 2021 | $147,748 | +138.3% | 43,648 | +97.1% | 0.00% | +100.0% |
| Q4 2020 | $62,009 | +32.8% | 22,146 | +19.1% | 0.00% | 0.0% |
| Q3 2020 | $46,676 | -91.4% | 18,596 | -53.7% | 0.00% | -90.0% |
| Q2 2020 | $545,549 | +95.3% | 40,173 | +9.0% | 0.01% | +66.7% |
| Q1 2020 | $279,399 | +14.6% | 36,860 | -4.4% | 0.01% | +50.0% |
| Q4 2019 | $243,769 | +108.9% | 38,571 | +29.6% | 0.00% | +100.0% |
| Q3 2019 | $116,671 | -31.3% | 29,763 | -15.2% | 0.00% | -33.3% |
| Q2 2019 | $169,797 | -36.0% | 35,082 | +8.3% | 0.00% | -40.0% |
| Q1 2019 | $265,290 | +48.0% | 32,392 | -0.0% | 0.01% | +25.0% |
| Q4 2018 | $179,190 | -2.2% | 32,403 | +56.1% | 0.00% | +33.3% |
| Q3 2018 | $183,302 | -99.9% | 20,759 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $207,174,000 | +53.3% | 20,759 | +46.4% | 0.00% | +50.0% |
| Q1 2018 | $135,144,000 | +63949.3% | 14,181 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $211,000 | -64.2% | 14,181 | -52.6% | 0.00% | -25.0% |
| Q3 2017 | $589,000 | +72.2% | 29,941 | +25.7% | 0.00% | +100.0% |
| Q2 2017 | $342,000 | +18.8% | 23,824 | -24.0% | 0.00% | 0.0% |
| Q1 2017 | $288,000 | -13.0% | 31,340 | -1.4% | 0.00% | 0.0% |
| Q4 2016 | $331,000 | +14.9% | 31,800 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $288,000 | +13.4% | 31,800 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $254,000 | -17.0% | 33,982 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $306,000 | +27.0% | 33,982 | +82.3% | 0.00% | 0.0% |
| Q4 2015 | $241,000 | +1168.4% | 18,636 | +854.7% | 0.00% | – |
| Q3 2015 | $19,000 | -90.2% | 1,952 | -89.7% | 0.00% | -100.0% |
| Q2 2015 | $194,000 | -24.8% | 18,890 | +103.4% | 0.00% | -50.0% |
| Q2 2014 | $258,000 | – | 9,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |